_0.jpg?#)
Brokers Set Expectations for Opus Genetics FY2030 Earnings
Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Research analysts at Brookline Capital Markets issued their FY2030 earnings estimates for shares of Opus Genetics in a research note issued to investors on Monday, August 10th. Brookline Capital Markets analyst K. Raja expects that the company will ea
Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Research analysts at Brookline Capital Markets issued their FY2030 earnings estimates for shares of Opus Genetics in a research note issued to investors on Monday, August 10th. Brookline Capital Markets analyst K. Raja expects that the company will ea
What's Your Reaction?
